CA2099920C - Modified chlorhexidine-adduct - Google Patents

Modified chlorhexidine-adduct

Info

Publication number
CA2099920C
CA2099920C CA002099920A CA2099920A CA2099920C CA 2099920 C CA2099920 C CA 2099920C CA 002099920 A CA002099920 A CA 002099920A CA 2099920 A CA2099920 A CA 2099920A CA 2099920 C CA2099920 C CA 2099920C
Authority
CA
Canada
Prior art keywords
adduct
chlorhexidine
tin
dental
plaque
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002099920A
Other languages
French (fr)
Other versions
CA2099920A1 (en
Inventor
Volker Rheinberger
Ulrich Salz
Peter Burtscher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivoclar AG
Original Assignee
Ivoclar AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivoclar AG filed Critical Ivoclar AG
Publication of CA2099920A1 publication Critical patent/CA2099920A1/en
Application granted granted Critical
Publication of CA2099920C publication Critical patent/CA2099920C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides
    • C07C279/265X and Y being nitrogen atoms, i.e. biguanides containing two or more biguanide groups

Abstract

A chlorhexidine adduct is described, which comprises one molecule of chlorhexidine with three molecules of hydrogen fluoride and one molecule of hydrogen tin trifluoride. The adduct displays a high antibacterial effectiveness against Streptococcus mutans even in very low concentrations.

Description

2~920 The invention relates to a chlnrh~Y~r~inf~ adduct which can be used as an antiseptic and in particular as an antLseptic in dentistry as well as a therapeutic and prophylactic anti-plaque agent.
5 In the attempt to inhibit or completely stop the f ormation of plaque and therefore also of caries, the effectiveness of substances with antibacterial properties such as chlorinated phenols, formaldehyde and quaternary ammonium compounds has been tested in the past. ~owever, these c, ~1~ have not been 10 introduced into practlce in view of their toxicity and their limited action spectrum.
The most effective anti-plaque agent at present is chlorhr~Y~-lin~
(1,6-bis-(N5-p-chlorophenyl-N'-diguanidino)-hexane) whichisused 15 particularly in the form of the water-soluble digluconate and also as the sparingly soluble diacetate and dihydrochloride (cf.
A.Scheie in J. Dent. Res. 68, 1609 (1989) and P. Gjermo in J.
Dent. Res. 68, 1602 (1989) ) .
20 Apart from these r~h1r~rh~ 1i n1~ compounds, chlorh~Yi~i n~
dihydrofluoride is also known which, according to DE-OS 21 58 150, is used as an antiseptic agent in transparent tooth gels.
Moreover, a mixture of ~hl~-rhr~Yidine, amine fluoride and tin 25 difluoride is known from I. Ostela and J. Tenovuo in Scand. J.
Dent. Res. 98, 1 (1990). This mixture can be used in tooth gels as a bactericide against cariogenic bacteria.
It has been shown that by using chlorhexidine as a 3 0 chemotherapeutic, bacteria of the type Streptococcus mutans can be countered effectively. Bacteria of this type play an essential role in the formation of caries on human teeth. It is therefore assumed that by reducing their quantity on the surface of teeth, the formation of caries can be effectively prevented (cf. I.
ostela and J. Tenovuo in Scand. J. Dent. Res. 98, 1 ( 1990) ) . ~t~
... . . . . ... , . , . . , ~

2~9~920 ~ - 2 -The bactericidal action which -hlqrhf~Y;cl;n~ exerts against bacteria of the type Strepto~ occl~ mutans iY, however, severely weakened if it is used in low concentrations. Even f-hl~rh~Y;~lln~
is, therefore, sub~ect to significant limitations in practical applications where reducing the amount of tooth plaque is important, which otherwise can lead to the formation of parodontosis and caries. Furth~ , the use of chlr)rheYi~lin~
in higher concentrations can result in undesirable discolorations of the tongue, teeth, prostheses and fillings (cf. L. Flqtra, P.
G~ermo, G. Rolla and J. Waerhaug in Scand. J. Dent. Res. 79, 119 ( 1971 ) ) .
Tin ions show a significant anti-caries action and a plaque-inhibiting effect. Firstly, the metabolism of the microorganisms 15 present in the plaque is disrupted (see e.g. J.E. Ellingsen, B.
Svatun and G. Rolla, Acta Odontol. Scand. 38, 219 (1980) and N.
Tinanoff, J.M. Brady and A. Gross, Caries Res. 10, 415 (1976)), and, secondly, tin (II) ions are deposited on the surface of the tooth and form acid-resistant precipitates there, together with 20 fluoride, calcium and phosphate ions (see e.g. J.E. Ellingsen, Scand. J. Dent. Res. 94, 229 (1986) and J.E. Ellingsen and G.
Rolla, Scand. J. Dent . Res . 95, 281 ( 1987 ) ) .
It is therefore the ob~ect of the invention to provide a 25 chlorh~Yi~linl~ adduct which, as an anti-plaque agent, effectively counters the formation and growth of tooth plaque even in very low concentrations, which can desensitize sensitive tooth necks and moreover which, through fluoride release, is capable of protecting the tooth enamel against fi~ n~r;~ atiOn, 30 particularly demineralisation by acids.
This ob~ect is surprisingly achieved by the ~hl~rh~x~in~ adduct according to claim 1 and the process for its production according to claims 2, 3 and 4 and its use according to claims 5 and 6.

` ~ 2~3~92~
- 2a -Preferred embodiments of the invention will now be described, with reference to the accompanying drawings, in which:
Fig 1 is an IR spectrum of the chlorhexidine adduct of the present invention;
Fig 2 is a secondary ions mass spectrometry of Example 3;
Fig 3 is a graph showing f luoride release over time according to Examples 4 and 5; and Fig 4 is a graph showing chlorhexidine release over time c~cording to Exa~l^e 4 .In~l 5.

/

2~9~920 .

The chlnrh~ n~ adduct according to the inventLon is a compound of the following formula:
Cl-~3 -NX-C-~-C~ - ( C~2 ) 6-~H-C-~H-C-~ 3 -C1 ~H NE~ NH ~I
3 ~IF ~IsnFs or its hydrates.
The adduct displays the IR spectrum according to Figure 1. The exact molecular structure of the adduct according to the invention i8 not known. ~3asically, it is possible that the adduct accordlng to the invention consists of electrically neutral molecules or is present in the form of ion5 and hence as a salt.
The adduct according to the invention is produced by reacting a chlr,rh~i~lln~ salt (preferably rhlnrhi~ n.o 1;qll~rnn~te), tin difluoride and hydrogen fluoride in a molar ratio of 1: 1 to 4 4 to 8 in a mixture of 3: l parts by volume ethanol/water as solvent and separating the precipitate formed.
The rhlnrh~ n~ according to the invention is preferably prepared by carrying out the reactLon at room temperature with a chlnrh~Yi~in~ salt to tin ~l~fll~nri~l~ to ILYd~UYI::~ fluoride molar ratio of 1: 4: 6. The yields thus obt~n~hl~ are 90 to almost 100% .
Increased temperatures are dlsadvantageous when carrying out the productlon process since they promote the formation of mi~ed 3 o products with a lower tin f luoride content .
A reaction time of 24 hours is usually sufficient to achieve a complete reaction. The reaction time can, however, vary depending on the reaction parameters selected. The best-suited reaction 2Q9~920 time for the case in question can, however, be ~lPtPrminPfl easily by routine Plrrl~r; ts.
The chlt~rhR~ inP adduct formed by the reaction prP~l~ ;n;-ntly as S precipitate Ls removed and purified, preferably by filtration and subsequent washing with water and acetone. By working-up of the mother liquors, further chlorhexidine adduct can be obtained, so that overall yields of 90 to almost 10096 are obtainable. The purified product is then dried in a conventional way and 10 afterwards exists in the form of hydrates with varying levels of water, dPr~n~lin~ on the degree of drying.
Because of its strong antibacterial action, the chlorhPY;~linP
adduct according to the invention can be used as a therapeutic 15 or prophylactic anti-plaque agent. In doing so, it prevents the formation of plaque and inhibits the growth of films already present on the tooth. Diseases which are caused by the presence of plaque, such as parodontosis, caries and gingivitis, are therefore able to be tackled effectively with the chlorhP~ nP
20 adduct according to the invention. Furthermore, it can contribute to the desensitizing of sensitive tooth necks. It is preferably used in dental materials, such as tooth v~rn;RhP~, fissure sealants, prophylactic pastes, mouthwashes, toothpicks, dental floss, dental chewing-gum, wound dressings, dental creams, 2~ gingiva ~r~;nPrS, disinfectants for protheses and impression materials, drying agents, under-f illing materials, cements, filling materials, adhesives and endodontic materLals . The adduct according to the invention can be deposited on a solid substrate, such as a toothpick or dental floss, or incorporated into dental materials, such as provisional filling materials and fissure sealants .
Of particular advantage is the incorporation of the adduct according to the invention in dental materials which are to remain in the oral cavity for a limited period of time, such as provisional filling materials, wound dressings, impression materials and t-o~rnr~ry cements. If the adduct according to the invention is incorporated for example into a provisional filling material, one obtains, after its removal, a germ-free cavity into 5 which the final filling can immediately afterwards be placed.
Since the chlnrh~ ;; n-~ adduct is only very slightly soluble in common solvents, it is preferably incorporated into the said dental materials as a solid. It is added to the dental materials in quantities of 0.1 to 20 wt.%, preferably 1 to 10 wt.96 and particularly preferably 3 to 7 wt.g~, relative to the total weight of the material. Examples of suitable dental materials are those which contain 10 to 95 wt. 9s poly ~ ~hl e organic binder, 5 to 90 wt.96 inorganic and/or organic fillers and 0.01 to 5 wt.%
15 catalysts, relative to the weight of the total material.
Furthermore, solutions containing 0.03 to 0.001 wt.96 of the adduct according to the invention can be used. Suitable as solvents are e.g. water, ethanol, acetone, ethyl acetate, 20 triethylene glycol dimethacrylate and ~ nef~;nl dimethacrylate.
Further, synthetic or natural resins can be used which are soluble in common solvents and become hard af ter evaporation of the solvent. Examples for such resins are shellac, benzoin resin, 25 polyvinyl pyrrolidone and colophony.
A further preferred application of ~he chlnrh~ i n~ adduct is that as a therapeutic or prophylactic anti-plaque agent. It prevents the formation of plaque and inhibits the growth of plaque already present. Diseases which are caused by the presence 30 of plaque, e.g. parodontosis, primary and secondary caries and gingivitis, can therefore be combatted effectively with the chlorhexidine adduct according to the invention.
As regards its bactericidal effectiveness, the nhlnrh~Yirl;nf~
adduct according to the invention is fully comparable in a _ _ _ _ _ _ _ _ _ _ _ _ . . , . . .... . . . . . . _ . .. . . . ..... _ _ ... . .

2~9~2~

concentration of 0.03 wt.96 with ~hlnrhf~ nP, which at present is regarded as the most effective anti-plaque agent.
Surprisingly, however, the effectiveness of chl~rh~YI~linP is significantly surpassed if both are used in concentrations less 5 than or equal to 0 . 01 wt . 96 . In this concentration range, the chlnrhPY; ~1 i nQ adduct according to the invention is even clearly superior to tin difluoride, a compound known to have very good bactericidal properties.
10 The superiority of the adduct according to the invention especially in low concentrations is of particular significance for practical applications. For, as a result of the rPrr-npnt salivation in the oral cavity, the active ingredients used are continuously diluted. An actlve ingredient, such as the 15 chlorhP~ inP adduct according to the invention, which shows a strong bactericidal effect even in low concentrations, is theref ore of particular advantage .
Finally, the high fluorine content of the adduct ac~nrlin~ to the 20 invention means that it can effect h~r~iPnin~ of the tooth enamel through fluoridization and therefore can also efectively protect against the formation of caries in this respect. The adduct according to the invention further shows the aforementioned effect of tin ions.

The adduct according to the invention can be worked in or applied on dental materials such as inter alia the aorementioned filling compositions, dental v~rni~hP~, fissure sealants, prophylactic pastes, tooth-picks, dental floss, dental chewing-gum, wound 30 dressings, dental creams, gingiva trainers, disinfectants for protheses and impression materials, drying agents, under-filling materials, cements, filling materials, adhesives and endodontic materials, or applied on the teeth in the form of many different dental treatment agents, such as toothpastes, tooth gels, tooth v~rni~hP~ or mouth rinses.
_ _ _ _ .

2~ D

The invention is described in more detail in the following examples .
Example 1 To produce the chlorh~Y;r1;n~ adduct according to the invention, 480 ml ethanol/water (3:1) were introduced first and 12.6 g (0.08 mole) tin difluoride and 6 g of a 40 % HF solution (0.12 mole) dissolved therein. 85 ml (corresponding to 90 g) (0.02 mole) of an aqueous 20% chlorh~Y;~lin~ digluconate solution were added dropwise with stirring within an hour. After a further 5 hours stirring, the precipitate formed was filtered off and washed three times with 50 ml ethanol/water (3:1). Further product crystallised out from the mother liquor within a week. Drying of the precipitate obtained was carried out in the drying cupboard at 50C. The yield of adduct was almost quantitative.

The IR spectrum (RBr pressed disk) is reproduced in Figure 1.
The ~lementary analysis shows that the product is rhl~rh~Y~in~
trihydrofluoride-hydrogen tin trifluoride with 2 moles crystal water.
C22H3ONIocl2 3 HF ~ HSnF3 ~ 2 H20 ~IW = 778 . 2 Elementary analysis:
found theoretical C 34.48% 33.96%
H 4.56% ~.40%
N 18 . 02% 18 . 00%
Cl 9 . 06% 9 . 11%
F 14 . 58% 14 . 65%
Sn 14 . 45% 15 . 259 H2O ) 4 . 84% 4 . 63%

}i20 content de~rmi nl~d by the ~arl Fischer method (Note: The theoretical value of 15 . 2596 for tin is not achieved in the elementary analysig since chlnrh~ nl~
hexahydrof l i~nr~ forms as a by-product during the synthesis in a yield of about 59~. The value for tin therefore falls, whilst a higher value is measured for carbon. ) Solubility:
Water 0 . 03 wt . 96 Ethanol 0 . 02 wt . 96 l~xample 2 The antibacterial effectiveness of the t-hlclrh~r;flinP adduct 15 according to the invention was demonstrated in the agar-diffusion test with StrePtoCOcCuS mutans.
For this, culture suspensions of Stre~tococcus mutans were introduced in liquid yeast-extract-dextrose-agar. After solidification of the agar plates, a basin of 10 mm diameter was cut out. Into this were poured 0.1 ml of the respective test 20 solution. The samples were prepared in duplicate in each case and the diameters of the zones of inhibition were measured after 24-hour incubation at 37C. The results of these tests are set out in the following Table I.

20~9~
g Table I
Inl~bition 2 one diameters Concentration Solution A Solution B SQlution C
0 . 03 wt. % 17 mm 16 mm 20 mm O . 01 wt. 96 13 mm 15 mm ll mm 5 0 . 003 wt . 96 ll mm 11 mm 10 mm no effectiveness Solution A: Aqueous solution of chlorh~Y;~;n~ digluconate Solution B: Aqueous solution of the chlorhf~Y;~;n~ adduct according to the invention Solution C: Aqueous solution of tin dif luoride The test result show that at a concentration of 0 . 03 wt. 96 the antibacterial effectiveness of the chlnrh~Y;~;;n~ adduct according to the invention against Streptococcus mutans i5 comparable with that of ~hlorheY;ci;n~ digluconate, whilst tin difluoride displays an even stronger action at this concentration. With increasing dilution, however, the effectiveness of the known compounds falls sharply, in the case of tin rl;fltlnri~ at a concentration of O . O 0 3 wt . 9~ even to the extent that an anti-bacterial ef f ect can no longer be detected. In contrast to this, the antibacterial effectiveness of the adduct according to the invention is still very high even at concentrations of 0 . Ol to 0 . 003 wt. 96 . Its superiority especially at low concentrations thus makes it a very ef f ective anti-plaque agent .
EYam~le 3 A dental material as described in Example 4 was deposited in a layer of ca. 2 mm on the surface of an absolutely plane-parallel, tin-free hydroxyl-apatite testpiece and polymerised for 40 _ _ . , , . . _ .. _ .. . . _ _ _ _ . .

~992~

seconds with the Heliomat~ (light apparatus from Vivadent).
Afterwards, the thus-coated testpiece was stored for 12 hours at 37C in distilled water. The poly ~ on layer was then removed with microscopic control and the tin content on the 5 hydroxyl apatite surface was analyzed by means of SI~IS (secondary ions mass spectrometry). This analysis process is described in Caries Res. 20, 419 (1986).
~he result obtained is depicted in Figure 2 and shows that a considerable portlon of the tin present in the dental material 10 was deposited on the surface of the hydroxyl apatite.
l~amPle 4 A light-curing fissure sealant contains the following ~ ~ntS:
56 . 08 wt. % Bis-phenol A-glycidyl methacrylate (Bis-Gl~A) 36 .1 wt. % Triethylene glycol dimethacrylate 0 . 45 wt . % Cyanoethylmethyl aniline 0 . 25 wt. % DL-camphor quinone 2.1 wt.% TiO2 0 . 02 wt. % 2, 6-di-tert. -butyl-p-cresol 5 . 0 wt . % Chlorh~ ~ i nf~ adduct The light-curable fissure sealant was obtained by mixing all the components. This was applied with a paint-brush onto the fissures of a molar and cured for 20 sec with the Heliolux' light-curing apparatus from Vivadent/Liechtenstein. The fissures were sealed 25 p-~r---nf-ntly in this way and, through the fluoride release of the chlorhexidine adduct incorporated in the sealant, excellent caries protection was obtained in the occlusal region.
By ;l~lmisring 1 to 5 wt.% of the chl~-rh~Y;-lin~ adduct to the fissure sealant basic formulation, no reduction in the degree of through-hardening was observed, as the following values for .

2Qg9~20 Vickers hardness show:
HV 0 . 5 Fissure sealant without ~h7nrh~ in-~ adduct 188 MPa Fissure sealant + 1% chlnrh~ ;n~ adduct 203 MPa Fissure sealant + 39~ ~hlorh~ in~ adduct 211 NPa Fissure sealant + 5~ chlnrhf~riflin~o adduct 184 ~Pa To demonstrate the chlnrh.oYi-linf~ and fluoride migration, 10 testpieces each with a diameter of 50 mm and a height of 0 . 5 mm were stored in dist. water at 37C. The concentration of fluo:ride ions was det~rmin~d using a fluoro-electrode, and the chlnrh~ 1 i n~ concentration was measured by means of W-10 spectroscopy. The results are set out below in Table II.
Table II
Cumulative fluoride and chlorh~yi~linf~ release ~igration time Fluoride Chlnrh~; ~i i n~
[days] release release [ llm/cm2] [ ,ug/cm2]
1.26 4.30 2 1.97 5.41 3 2.61 5.96 4 3.13 6.36 7 4.57 7.11 5 . 77 8 . 37 17 8 . 01 9 . 07 24 9 . 83 9 . 77 11 . 21 10 . 37 44 13 . 87 10 . 93 86 18 . 49 11 . 01 149 22 . 91 11 . og ` ~Dg~920 The results are represented graphically in Figures 3 and 4.
Examl~le 5 A light-curing dental plastic with relatively high water absorption and theref ore high active ingredient release ( e . g .
5 suitable as provisional filling material or as a wound dressing) has the following composition:
41. 4 wt . % polyester urethane dimethacrylate 0 . 25 wt. % cyanoethylmethyl aniline 0 .15 wt . % DL-camphor quinone 0 . 02 wt . % 2, 6-di-tert . -butyl-p-cresol 33 . 25 wt. % splinter polymerisate l9 . 93 wt. % finely-dispersed silanised SiO2 5 . 0 wt . % chlnrh~ i n~ adduct The splinter polymerisate consists of:
lS 59.4 % urethane dimethacrylate 40 % finely dispersed silanised SiO2 0 . 6 % benzpinacol These c~ ts are mixed together and polymerised at 120C. The filled polymerisate is ground to a polymer powder. The _~huux 20 finely-dispersed silanised SiOz is Aerosil~ OX 50 from Degusaa AG .
A light-curing dental material was obtained by mixing all the ,- ,r.n~ntS.
The water absorption of dental filling composites normally lies 25 in the region of 1 wt. ~ . However, this material shows a water absorption in the region of 3 wt.% (3 weeks EIzO storage at 37C).
Chlnrh~ r1~nf~ and fluoride migration:
. _ _ _ _ 2 ~

The cumulatlve fluoride and chlnrh~xl~lin~ release is 2,, ri~ed in the following table III.
Table III
5 ~ligration time Fluoride Chlorhexidine [ days ] release release [ llm/cm2 ] [ llm/cm2 ]
1.67 10.4 2 2.64 16.3 3 3.52 21.?
4 4 . 29 26 . 5 7 5.64 32.1 6 . 87 37 . 3 17 8.97 43.5 24 10 . 72 49 . 3 11.92 53.5 44 14 . 02 59 . 8 86 17.38 67.3 149 19 . 90 76 . 8 20 The results are represented graphically in Figures 3 and 4.
Microbioloqical action As the migration ~er; Ls show, signif icant quantities of fluoride and chlorh~xi-1~nf~ are released from this dental material, so that even in this combination a suf f icient 25 inhibition of the growth of microorganisms is to be expected.
Since not all microorganisms react equally on released active ingredients, investigations were conducted using the following microbes .

,9.g~
.

Gram-positive bacteria: Streptococcus mutans Staphylococcus aureus Gram-negative bacteria: Pæ~lt~t i~.C auruginOsa Escherichia coli Fun us: Candida albicans 10 g Testpieces (d = 10 mm, h = 2 mm) were introduced into the moist microorganism culture& at 37C over a period of 24 hours and then 15 the zone of inhibition was dett~rmint~
Zone of inhibition diameter [ mm ]
20 Streptococcus mutans 13 Staphylococcus aureus 14 Pseudomonas auruginosa 16 Escherichia coli 14 25 Candida albicans 10 (no effect) With the exception of Candida i~lhit.~n~t, a clear inhibition of growth in these various microorganlsms is detectable.

Claims (6)

1. Chlorhexidine adduct with the following formula 3 HF HSnF3 or its hydrates.
2. A process for preparing the chlorhexidine adduct according to claim 1 comprising:
a) reacting a chlorhexidine salt, tin difluoride and hydrogen fluoride in a molar ratio of 1: 1 to 4 : 4 to 8 in a mixture of 3:1 parts by volume ethanol/water as solvent, and b) separating the resulting precipitate.
3. A process according to claim 2 comprising:
a) reacting the chlorhexidine salt, tin difluoride and hydrogen fluoride in a molar ratio of 1 : 4 : 6 and b) carrying out step a) at room temperature.
4. A process according to claim 2 or 3, wherein chlorhexidine digluconate is used as said chlorhexidine salt.
5. Use of the chlorhexidine adduct or its hydrates according to claim 1 as an antiseptic.
6. Use of the chlorhexidine adduct or its hydrates according to claim 1 as an agent for the prevention of caries.
CA002099920A 1992-07-08 1993-07-06 Modified chlorhexidine-adduct Expired - Fee Related CA2099920C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4222821.2 1992-07-08
DE4222821A DE4222821C2 (en) 1992-07-08 1992-07-08 Modified chlorhexidine adduct

Publications (2)

Publication Number Publication Date
CA2099920A1 CA2099920A1 (en) 1994-01-09
CA2099920C true CA2099920C (en) 1996-12-24

Family

ID=6462979

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002099920A Expired - Fee Related CA2099920C (en) 1992-07-08 1993-07-06 Modified chlorhexidine-adduct

Country Status (6)

Country Link
US (1) US5393516A (en)
EP (1) EP0578344B1 (en)
AT (1) ATE141912T1 (en)
AU (1) AU655547B2 (en)
CA (1) CA2099920C (en)
DE (2) DE4222821C2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA965340B (en) * 1995-06-30 1997-01-27 Interdigital Tech Corp Code division multiple access (cdma) communication system
US6293287B1 (en) * 1996-09-13 2001-09-25 Gillette Canada Inc. UV-cured resin-coated dental floss
US5967153A (en) * 1996-10-15 1999-10-19 Gillette Canada Inc. Emulsion coated dental floss containing chemotherapeutic active agents
MXPA01003045A (en) * 1998-09-24 2003-07-11 Advantage Dental Products Inc Calcified tissue facing preparation containing antimicrobial agent.
US6726899B2 (en) 1998-09-24 2004-04-27 Advantage Dental Products, Inc. Calcified tissue facing preparation containing antimicrobial agent
DE19921727A1 (en) * 1999-05-12 2000-11-16 Susanne Szep Fluoriding composition for treating tooth surfaces to prevent caries and reduce sensitivity, containing hydrogen fluoride to form strongly bound fluoride complexes on surface
DE19921950A1 (en) * 1999-05-12 2000-11-16 Susanne Szep Dentine adhesives containing hydrogen fluoride for use in dental restorative work
EP1272152B1 (en) * 2000-04-03 2012-03-07 CHX Technologies Inc. Use of chlorhexidine in the prevention of root caries
DE10261241A1 (en) * 2002-12-20 2004-07-15 3M Espe Ag Dental material with bacteriostatic and / or bactericidal substances
US20060254988A1 (en) * 2005-05-10 2006-11-16 Confirm Monitoring Systems, Inc. Methods and compositions for the treatment of water
EP1787627A1 (en) 2005-11-17 2007-05-23 3M Innovative Properties Company Anti-microbial dental impression material
AU2006325820B2 (en) 2005-12-12 2013-02-14 Allaccem, Inc. Methods and systems for preparing antimicrobial films and coatings
NZ579785A (en) 2007-02-21 2012-06-29 Allaccem Inc Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20090324516A1 (en) * 2008-06-27 2009-12-31 Muscle Dave P Composition and Method for Enhancing Flouride Uptake Using Bioactive Glass
KR20170058977A (en) 2014-09-17 2017-05-29 개리슨 덴탈 솔루션즈, 엘엘씨 Dental curing light
RU2696259C2 (en) 2017-10-23 2019-08-01 Общество С Ограниченной Ответственностью "Сан Системз" Solubilization of the chlorhexidine base, antiseptic and disinfectant compositions
DE102019000321A1 (en) 2019-01-14 2020-07-16 Beuth Hochschule Für Technik Berlin Oral sustained release polymer composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1304090A (en) * 1970-11-27 1973-01-24
US4069310A (en) * 1970-11-27 1978-01-17 Colgate Palmolive Company Method for the manufacture of clear dentifrices
US5098711A (en) * 1988-11-14 1992-03-24 Ira Hill Method of treating the oral cavity with dental floss containing chemotherapeutic agents
DE4135397C2 (en) * 1991-10-26 1994-01-20 Ivoclar Ag Schaan Chlorhexidine adduct, process for its preparation and its use

Also Published As

Publication number Publication date
AU655547B2 (en) 1994-12-22
DE59303552D1 (en) 1996-10-02
ATE141912T1 (en) 1996-09-15
DE4222821A1 (en) 1994-01-13
EP0578344A1 (en) 1994-01-12
DE4222821C2 (en) 1994-09-22
CA2099920A1 (en) 1994-01-09
EP0578344B1 (en) 1996-08-28
US5393516A (en) 1995-02-28
AU4150893A (en) 1994-01-13

Similar Documents

Publication Publication Date Title
CA2099920C (en) Modified chlorhexidine-adduct
EP0264660B1 (en) Use of a dental material for combating caries and periodontosis
AU648892B2 (en) Dentifrice composition
CA1322961C (en) Oral composition
US4638823A (en) Fluoride-coated dental floss
SE447626B (en) ORAL COMPOSITION
US5158763A (en) Non-staining anti-bacterial oral composition
JPH02200618A (en) Dentifrice containing aminoalkyl silicon modified
EP0075446A2 (en) Anticaries composition
JP2975380B2 (en) Plaque formation inhibitor
US4820507A (en) Oral and dental hygiene preparations
EP2249764B1 (en) Tooth sealant
US5213615A (en) Dental material and method for the control of caries and paradentitis
CA2079561C (en) Chlorohexidine adduct and method of preparing same
EP0026252A1 (en) Oral hygiene composition
Bonesvoll Retention and plaque-inhibiting effect in man of chlorhexidine after multiple mouth rinses and retention and release of chlorhexidine after toothbrushing with a chlorhexidine gel
SE434596B (en) MUNVARDS COMPOSITION CONTAINING MEDITERRIC ACID OR HEXAHYDROMELLITIC ACID FOR ANTICIPATION OF DENTAL SPOTS CAUSED BY AN INHIBITIVE NON-BREAKING HYPHEN (8209) antibacterial inhibitor
JPH06122617A (en) Composition for oral hygiene material
US4296095A (en) Dental and mouth care preparations
US4020019A (en) Anticaries agents
DE3001575A1 (en) Anti-plaque oral hygiene compsn. - contg. chlorhexidine and/or alexidine, or salt derivs., and zinc salt to prevent teeth discolouration
JPH0560444B2 (en)
WO2023194819A1 (en) Oral care compositions, methods, and kits
JP2002205929A (en) Composition for oral cavity
JPS62207207A (en) Cariostatic composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed